Please provide your email address to receive an email when new articles are posted on . WAIKOLOA, Hawaii — With several good MIGS options, the choice often comes down to matching the procedure with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Iantrek announced it closed $23 million in Series B ...
IRVINE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for ...
Research and Markets has announced the addition of the "Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery, By End User, By Region, By Country): Opportunities and ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...
Glaukos iStent inject W is the smallest device ever approved by the FDA It was about two years ago this summer when Glaukos Corp. (NYSE: GKOS) received notice from the federal government that it would ...
A new micro-surgical device from Glaukos Corp. has received clearance from the Food and Drug Administration. The $2.5 billion-valued ophthalmic device and drugmaker in San Clemente (NYSE: GKOS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results